CoChat

Adolescent PCOS: a postpubertal central obesity syndrome

Open access
Ibáñez, Lourdes, de Zegher, Francis · 2023 · Trends in Molecular Medicine
Cited by 97

The DOI matches its Crossref record; 23 of the 23 references it cites were found in a registry or an index.

Abstract

Adolescent polycystic ovary syndrome (PCOS) is a highly prevalent, reversible, endocrine-metabolic mode essentially driven by ectopic fat, which, in turn, often results from a mismatch between early adipogenesis and later lipogenesis, or between prenatal and postnatal weight gain. The key features of adolescent PCOS are menstrual irregularity and androgen excess (hirsutism, acne, and/or high testosterone). Adolescent PCOS is frequently preceded by rapid maturation (early variants of adrenarche/pubarche and puberty/menarche, also accelerated by ectopic fat) and is diagnosed between 2 and 8 years after menarche, thus during late adolescence or early adulthood. Treatment of adolescent PCOS should not only focus on symptoms, but also reduce the amount of ectopic fat, thereby aiming for an overall state of preconception health.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.molmed.2023.02.006

Cites

23 of 23 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Research works printed but not linked: 60

  1. Farland, 2022, Polycystic ovary syndrome and risk of adverse pregnancy outcomes: a registry linkage study from Massachusetts, Hum. Reprod., 37, 2690, 10.1093/humrep/deac210 · DOI
  2. Ryu, 2021, Risk of type 2 diabetes is increased in nonobese women with polycystic ovary syndrome: the National Health Insurance Service-National Sample Cohort study, Fertil. Steril., 115, 1569, 10.1016/j.fertnstert.2020.12.018 · DOI
  3. Falzarano, 2022, Nonalcoholic fatty liver disease in women and girls with polycystic ovary syndrome, J. Clin. Endocrinol. Metab., 107, 258, 10.1210/clinem/dgab658 · DOI
  4. de Zegher, 2009, Adipose tissue expandability and the early origins of PCOS, Trends Endocrinol. Metab., 20, 418, 10.1016/j.tem.2009.06.003 · DOI
  5. Elks, 2014, Associations between genetic obesity susceptibility and early postnatal fat and lean mass: an individual participant meta-analysis, JAMA Pediatr., 168, 1122, 10.1001/jamapediatrics.2014.1619 · DOI · Paper page
  6. de Zegher, 2019, Towards a simple marker of hepato-visceral adiposity and insulin resistance: the Z-score change from weight-at-birth to BMI-in–childhood, Pediatr. Obes., 14, 10.1111/ijpo.12533 · DOI
  7. Sebastiani, 2016, The sequence of prenatal growth restraint and postnatal catch-up growth leads to a thicker intima-media and more pre-peritoneal and hepatic fat by age 3-6 years, Pediatr. Obes., 11, 251, 10.1111/ijpo.12053 · DOI · Paper page
  8. Ibáñez, 2006, Early development of adiposity and insulin resistance after catch-up weight gain in small-for-gestational-age children, J. Clin. Endocrinol. Metab., 91, 2153, 10.1210/jc.2005-2778 · DOI · Paper page
  9. Ong, 2020, Mismatch between poor fetal growth and rapid postnatal weight gain in the first 2 years of life is associated with higher blood pressure and insulin resistance without increased adiposity in childhood: the GUSTO cohort study, Int. J. Epidemiol., 49, 1591, 10.1093/ije/dyaa143 · DOI
  10. Charkaluk, 2004, Premature pubarche as an indicator of how body weight influences the onset of adrenarche, Eur. J. Pediatr., 163, 89, 10.1007/s00431-003-1358-9 · DOI
  11. Ong, 2004, Opposing influences of prenatal and postnatal weight gain on adrenarche in normal boys and girls, J. Clin. Endocrinol. Metab., 89, 2647, 10.1210/jc.2003-031848 · DOI · Paper page
  12. Neville, 2005, Precocious pubarche is associated with SGA, prematurity, weight gain, and obesity, Arch. Dis. Child., 90, 258, 10.1136/adc.2004.053959 · DOI · Paper page
  13. Liimatta, 2018, Trajectories of growth and serum DHEAS and IGF-1 concentrations in girls with a history of premature adrenarche: attenuation of the phenotype by adulthood, Front. Endocrinol., 9, 375, 10.3389/fendo.2018.00375 · DOI
  14. Ibáñez, 1998, Precocious pubarche, hyperinsulinism, and ovarian hyperandrogenism in girls: relation to reduced fetal growth, J. Clin. Endocrinol. Metab., 83, 3558, 10.1210/jcem.83.10.5205 · doi:10.1210/jcem.83.10.5205 · Paper page
  15. Harbulot, 2021, Prevalence and clinical characteristics of isolated forms of central precocious puberty: a cohort study at a single academic center, Eur. J. Endocrinol., 184, 243, 10.1530/EJE-20-0862 · DOI
  16. de Zegher, 2021, On the rising incidence of early breast development: puberty as an adaptive escape from ectopic adiposity in mismatch girls, Eur. J. Endocrinol., 185, L1, 10.1530/EJE-21-0287 · DOI
  17. Kaltenbach, 2017, Thyroid dysfunction and hepatic steatosis in overweight children and adolescents, Pediatr. Obes., 12, 67, 10.1111/ijpo.12110 · DOI
  18. Kim, 2022, Obesity is associated with adolescent hyperandrogenemia in girls aged 6-18, National Health and Nutrition Examination Survey (NHANES) 2013–2016, J. Endocr. Soc., 6, A679, 10.1210/jendso/bvac150.1404 · doi:10.1210/jendso/bvac150.1404
  19. Su, 2020, Factors affecting bone maturation in Chinese girls aged 4–8 years with isolated premature thelarche, BMC Pediatr., 20, 356, 10.1186/s12887-020-02256-w · DOI
  20. Sánchez-Garrido, 2022, Early programming of reproductive health and fertility: novel neuroendocrine mechanisms and implications in reproductive medicine, Hum. Reprod. Update, 28, 346, 10.1093/humupd/dmac005 · DOI
  21. Argente, 2023, Molecular basis of normal and pathological puberty: from basic mechanisms to clinical implications, Lancet Diabetes Endocrinol, 11, 203, 10.1016/S2213-8587(22)00339-4 · DOI
  22. Lass, 2011, Effect of lifestyle intervention on features of polycystic ovarian syndrome, metabolic syndrome, and intima-media thickness in obese adolescent girls, J. Clin. Endocrinol. Metab., 96, 3533, 10.1210/jc.2011-1609 · DOI · Paper page
  23. Legro, 2010, Associations of birthweight and gestational age with reproductive and metabolic phenotypes in women with polycystic ovarian syndrome and their first-degree relatives, J. Clin. Endocrinol. Metab., 95, 789, 10.1210/jc.2009-1849 · DOI · Paper page
  24. Ünlütürk, 2016, Evolutionary determinants of polycystic ovary syndrome: part 1, Fertil. Steril., 106, 33, 10.1016/j.fertnstert.2016.05.010 · DOI
  25. Ibáñez, 1999, Anovulation after precocious pubarche: early markers and time course in adolescence, J. Clin. Endocrinol. Metab., 84, 2691
  26. Peña, 2020, Adolescent polycystic ovary syndrome according to the international, evidence-based guideline, BMC Med., 18, 72, 10.1186/s12916-020-01516-x · DOI · Paper page
  27. Peña, 2022, Criteria for diagnosis of polycystic ovary syndrome during adolescence: literature review, Diagnostics, 12, 1931, 10.3390/diagnostics12081931 · DOI
  28. van Hooff, 1999, Endocrine features of polycystic ovary syndrome in a random population sample of 14-16 year old adolescents, Hum. Reprod., 14, 2223, 10.1093/humrep/14.9.2223 · DOI · Paper page
  29. Davis-Kankanamge, 2016, The association between body mass index and androgen levels in adolescent girls with irregular menses or amenorrhea, Fertil. Steril., 106, 10.1016/j.fertnstert.2016.07.735 · doi:10.1016/j.fertnstert.2016.07.735
  30. Ferriman, 1961, Clinical assessment of body hair in women, J. Clin. Endocrinol. Metab., 21, 1440, 10.1210/jcem-21-11-1440 · DOI · Paper page
  31. Gambineri, 2013, Prevalence of hyperandrogenic states in late adolescent and young women: epidemiological survey on Italian high-school students, J. Clin. Endocrinol. Metab., 98, 1641, 10.1210/jc.2012-3537 · DOI · Paper page
  32. Salameh, 2014, Specificity and predictive value of circulating testosterone assessed by tandem mass spectrometry for the diagnosis of polycystic ovary syndrome by the National Institutes of Health 1990 criteria, Fertil. Steril., 101, 1135, 10.1016/j.fertnstert.2013.12.056 · DOI · Paper page
  33. Lennon, 2022, Preconception health optimization in women with polycystic ovary syndrome - how to find the time?, Curr. Opin. Endocrinol. Diabetes Obes., 29, 541, 10.1097/MED.0000000000000781 · DOI
  34. Moore, 2021, Weight management in adolescents with polycystic ovary syndrome, Curr. Obes. Rep., 10, 311, 10.1007/s13679-021-00437-x · DOI
  35. Simon, 2020, Poor sleep is related to metabolic syndrome severity in adolescents with PCOS and obesity, J. Clin. Endocrinol. Metab., 105, 10.1210/clinem/dgz285 · DOI · Paper page
  36. Mena, 2019, The effect of physical activity on reproductive health outcomes in young women: a systematic review and meta-analysis, Hum. Reprod. Update, 25, 541, 10.1093/humupd/dmz013 · DOI
  37. Rosqvist, 2019, Overeating saturated fat promotes fatty liver and ceramides compared with polyunsaturated fat: a randomized trial, J. Clin. Endocrinol. Metab., 104, 6207, 10.1210/jc.2019-00160 · DOI · Paper page
  38. Yu, 2022, Sleep duration and visceral adipose tissue: linear and nonlinear Mendelian randomization analyses, J. Clin. Endocrinol. Metab., 107, 2992, 10.1210/clinem/dgac551 · DOI
  39. Papaetis, 2022, GLP-1 receptor agonists, polycystic ovary syndrome and reproductive dysfunction: current research and future horizons, Adv. Clin. Exp. Med., 31, 1265, 10.17219/acem/151695 · DOI
  40. Kuo, 2022, HOTAIR interacts with PRC2 complex regulating the regional preadipocyte transcriptome and human fat distribution, Cell Rep., 40, 10.1016/j.celrep.2022.111136 · DOI
  41. Ibáñez, 2017, Normalizing ovulation rate by preferential reduction of hepato-visceral fat in adolescent girls with polycystic ovary syndrome, J. Adolesc. Health, 61, 446, 10.1016/j.jadohealth.2017.04.010 · DOI
  42. Ibáñez, 2020, Toward a treatment normalizing ovulation rate in adolescent girls with polycystic ovary syndrome, J. Endocr. Soc., 4
  43. Shorakae, 2019, Brown adipose tissue thermogenesis in polycystic ovary syndrome, Clin. Endocrinol., 90, 425, 10.1111/cen.13913 · DOI · Paper page
  44. Thuzar, 2019, Mineralocorticoid antagonism enhances brown adipose tissue function in humans: a randomized placebo-controlled cross-over study, Diabetes Obes. Metab., 21, 509, 10.1111/dom.13539 · DOI
  45. García-Beltran, 2020, Reduced circulating levels of chemokine CXCL14 in adolescent girls with polycystic ovary syndrome: normalization after insulin sensitization, BMJ Open Diabetes Res. Care, 8, 10.1136/bmjdrc-2019-001035 · DOI
  46. Ibáñez, 2008, Pioglitazone (7.5 mg/day) added to flutamide-metformin in women with androgen excess: additional increments of visfatin and high molecular weight adiponectin, Clin. Endocrinol., 68, 317, 10.1111/j.1365-2265.2007.03137.x · DOI · Paper page
  47. Li, 2020, Mechanisms by which adiponectin reverses high fat diet-induced insulin resistance in mice, Proc. Natl. Acad. Sci. U. S. A., 117, 32584, 10.1073/pnas.1922169117 · DOI · Paper page
  48. LaMoia, 2021, Cellular and molecular mechanisms of metformin action, Endocr. Rev., 42, 77, 10.1210/endrev/bnaa023 · DOI · Paper page
  49. de Zegher, 2021, The relative deficit of GDF15 in adolescent girls with PCOS can be changed into an abundance that reduces liver fat, Sci. Rep., 11, 7018, 10.1038/s41598-021-86317-9 · DOI
  50. Coll, 2020, GDF15 mediates the effects of metformin on body weight and energy balance, Nature, 578, 444, 10.1038/s41586-019-1911-y · DOI · Paper page
  51. Kincaid, 2022, Metformin and GDF15: where are we now?, Nat. Rev. Endocrinol., 19, 6, 10.1038/s41574-022-00764-6 · DOI
  52. Díaz, 2020, Low circulating levels of miR-451a in girls with polycystic ovary syndrome: different effects of randomized treatments, J. Clin. Endocrinol. Metab., 105, 10.1210/clinem/dgz204 · DOI
  53. Garcia-Beltrán, 2021, Gut microbiota in adolescent girls with polycystic ovary syndrome: effects of randomized treatments, Pediatr. Obes., 16, 10.1111/ijpo.12734 · DOI
  54. García-Beltrán, 2023, Raised thyroid stimulating hormone in girls with polycystic ovary syndrome: effects of randomized interventions, Horm. Res. Paediatr., 10.1159/000529183 · DOI
  55. Guarnotta, 2021, Predictive factors of polycystic ovary syndrome in girls with precocious pubarche, Endocr. Connect., 10, 796, 10.1530/EC-21-0118 · DOI
  56. Ibáñez, 2006, Metformin treatment to prevent early puberty in girls with precocious pubarche, J. Clin. Endocrinol. Metab., 91, 2888, 10.1210/jc.2006-0336 · DOI · Paper page
  57. Ibáñez, 2006, Metformin therapy during puberty delays menarche, prolongs pubertal growth, and augments adult height: a randomized study in low-birth-weight girls with early-normal onset of puberty, J. Clin. Endocrinol. Metab., 91, 2068, 10.1210/jc.2005-2329 · DOI · Paper page
  58. Ibáñez, 2004, Insulin sensitization early after menarche prevents progression from precocious pubarche to polycystic ovary syndrome, J. Pediatr., 144, 23, 10.1016/j.jpeds.2003.08.015 · DOI
  59. Bassols, 2023, Effects of half-dose spiomet treatment in girls with early puberty and accelerated bone maturation: a multicenter, randomized, placebo-controlled study protocol, Trials, 24, 56, 10.1186/s13063-022-07050-w · DOI
  60. Popovic, 2022, Gonadotropin-releasing hormone analog therapies for children with central precocious puberty in the United States, Front. Pediatr., 10, 10.3389/fped.2022.968485 · DOI

Cited by

See all 97

Metadata

Authors
Ibáñez, L., & de Zegher, F.
Venue
Trends in Molecular Medicine
Publisher
Elsevier BV
Published
2023-05
Volume
29
Issue
5
Pages
354-363
ISSN
1471-4914 (ISSN-L)
OpenAlex
W4353062899
Cited by
97
References
23
FWCI
5.79
Type
journal article
Language
en
Open access
hybrid
Licence
Funders
  • European Commission
  • Instituto de Salud Carlos III
  • Ministerio de Ciencia e Innovación
  • Horizon 2020 (899671)
  • European Regional Development Fund (PERIS-SLT017/20/000228, PI15/01078)
  • Horizon 2020 Framework Programme

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.